Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Dr. Leyland-Jones' main research interests are pharmacodynamics, pharmacokinetics and pharmacogenetics in oncological clinical trials; translation of preclinical models into the clinic; biomarker endpoints in Phase I/II clinical trials; and screening and mechanistic studies of novel targeted and chemotherapeutic anti-cancer agents.
Interview Questions
About Dr. Leyland-Jones
(Time:
0min
2sec
)
Why did you become interested in cancer research?
(Time:
0min
47sec
)
How will genotyping affect the development of individualized medicine?
(Time:
1min
43sec
)
How will individualized medicine affect the pharmaceutical economy?
(Time:
1min
44sec
)
How will individualized medicine affect insurance companies?
(Time:
1min
15sec
)
What is the greatest challenge you face treating a breast cancer patient?
(Time:
0min
52sec
)
What information should be given to a newly diagnosed cancer patient?
(Time:
1min
10sec
)
How does molecular profiling affect educators and students studying cancer?
(Time:
1min
12sec
)
What is the future of molecular profiling process?
(Time:
1min
34sec
)
What are your goals with genotyping or molecular profiling?
(Time:
0min
25sec
)
Top